These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 35834606)

  • 41. Antipsychotic medications and admission to psychiatric residential treatment facilities among youth in foster care diagnosed with disruptive behavior disorders.
    Rose RA; Lanier P; dosReis S
    Am J Orthopsychiatry; 2022; 92(4):474-482. PubMed ID: 35446103
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004.
    Depp C; Ojeda VD; Mastin W; Unützer J; Gilmer TP
    Psychiatr Serv; 2008 Oct; 59(10):1169-74. PubMed ID: 18832503
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Investigating geographic variation in use of psychotropic medications among youth in child welfare.
    Leslie LK; Raghavan R; Hurley M; Zhang J; Landsverk J; Aarons G
    Child Abuse Negl; 2011 May; 35(5):333-42. PubMed ID: 21620160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A best-worst scaling experiment to identify patient-centered claims-based outcomes for evaluation of pediatric antipsychotic monitoring programs.
    Mackie TI; Kovacs KM; Simmel C; Crystal S; Neese-Todd S; Akincigil A
    Health Serv Res; 2021 Jun; 56(3):418-431. PubMed ID: 33369739
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program.
    Menzin J; Boulanger L; Friedman M; Mackell J; Lloyd JR
    Psychiatr Serv; 2003 May; 54(5):719-23. PubMed ID: 12719504
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Visits to Primary Care and Emergency Department Reliance for Foster Youth: Impact of Medicaid Managed Care.
    Bright MA; Kleinman L; Vogel B; Shenkman E
    Acad Pediatr; 2018; 18(4):397-404. PubMed ID: 29081362
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Psychotropic medication in children and adolescents in the United States in the year 2004 vs 2014.
    Lopez-Leon S; Lopez-Gomez MI; Warner B; Ruiter-Lopez L
    Daru; 2018 Sep; 26(1):5-10. PubMed ID: 30159759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antipsychotic treatment for youth in foster care: Perspectives on improving youths' experiences in providing informed consent.
    Simmel C; Bowden CF; Neese-Todd S; Hyde J; Crystal S
    Am J Orthopsychiatry; 2021; 91(2):258-270. PubMed ID: 33983774
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Measurement of Metabolic Monitoring in Youth and Adult Medicaid Recipients Prescribed Antipsychotics.
    Edelsohn GA; Parthasarathy M; Terhorst L; Karpov IO; Schuster J
    J Manag Care Spec Pharm; 2015 Sep; 21(9):769-77, 777a-777cc. PubMed ID: 26308224
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trends in Use and Cost of Second-Generation Antipsychotics Among Children and Teens in Indiana Medicaid, 2004-2012.
    Goddard AW; Schwartz K; Hendrix K; Aalsma MC; Slaven J; Hancock EF; Lambert D; Downs S; Rosenman M
    Psychiatr Serv; 2016 Sep; 67(9):1030-4. PubMed ID: 27181731
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Use of Antidepressants, Antipsychotics, and Stimulants in Youth Residential Care.
    Oerbeck B; Overgaard KR; Hjellvik V; Lien L; Bramness JG
    J Child Adolesc Psychopharmacol; 2021 Jun; 31(5):350-357. PubMed ID: 33635152
    [No Abstract]   [Full Text] [Related]  

  • 53. Foster care, externalizing disorders, and antipsychotic use among Medicaid-enrolled youths.
    Vanderwerker L; Akincigil A; Olfson M; Gerhard T; Neese-Todd S; Crystal S
    Psychiatr Serv; 2014 Oct; 65(10):1281-4. PubMed ID: 25124057
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High-cost use of second-generation antipsychotics under California's Medicaid program.
    Stahl SM; Grady MM
    Psychiatr Serv; 2006 Jan; 57(1):127-9. PubMed ID: 16399974
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
    Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
    J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders.
    Mandell DS; Morales KH; Marcus SC; Stahmer AC; Doshi J; Polsky DE
    Pediatrics; 2008 Mar; 121(3):e441-8. PubMed ID: 18310165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Medicaid Quality Improvement Collaborative on Psychotropic Medication Prescribing for Children.
    Thackeray J; Crane D; Fontanella C; Sorter M; Baum R; Applegate M
    Psychiatr Serv; 2018 May; 69(5):501-504. PubMed ID: 29493415
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychiatric comorbidities and use of psychotropic medications in people with autism spectrum disorder in the United States.
    Houghton R; Ong RC; Bolognani F
    Autism Res; 2017 Dec; 10(12):2037-2047. PubMed ID: 28963809
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Psychotropic and cognitive-enhancing medication use and its documentation in contemporary long-term care practice.
    Rojas-Fernandez C; Mikhail M; Brown SG
    Ann Pharmacother; 2014 Apr; 48(4):438-46. PubMed ID: 24473493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Metabolic Testing for Adults in a State Medicaid Program Receiving Antipsychotics: Remaining Barriers to Achieving Population Health Prevention Goals.
    Morrato EH; Campagna EJ; Brewer SE; Dickinson LM; Thomas DS; Miller BF; Dearing J; Druss BG; Lindrooth RC
    JAMA Psychiatry; 2016 Jul; 73(7):721-30. PubMed ID: 27167755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.